vs

Side-by-side financial comparison of CRYO CELL INTERNATIONAL INC (CCEL) and PROVIDENT FINANCIAL HOLDINGS INC (PROV). Click either name above to swap in a different company.

PROVIDENT FINANCIAL HOLDINGS INC is the larger business by last-quarter revenue ($9.8M vs $7.8M, roughly 1.3× CRYO CELL INTERNATIONAL INC). PROVIDENT FINANCIAL HOLDINGS INC runs the higher net margin — 14.6% vs -48.7%, a 63.3% gap on every dollar of revenue. On growth, PROVIDENT FINANCIAL HOLDINGS INC posted the faster year-over-year revenue change (2.5% vs -2.3%). CRYO CELL INTERNATIONAL INC produced more free cash flow last quarter ($1.2M vs $1.0M). Over the past eight quarters, PROVIDENT FINANCIAL HOLDINGS INC's revenue compounded faster (2.3% CAGR vs -0.1%).

Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.

Provident Financial Holdings Inc is a bank holding company operating through its subsidiary Provident Savings Bank. It offers retail and commercial banking services including deposit products, mortgage loans, consumer lending and small business financing for local communities across California.

CCEL vs PROV — Head-to-Head

Bigger by revenue
PROV
PROV
1.3× larger
PROV
$9.8M
$7.8M
CCEL
Growing faster (revenue YoY)
PROV
PROV
+4.7% gap
PROV
2.5%
-2.3%
CCEL
Higher net margin
PROV
PROV
63.3% more per $
PROV
14.6%
-48.7%
CCEL
More free cash flow
CCEL
CCEL
$181.6K more FCF
CCEL
$1.2M
$1.0M
PROV
Faster 2-yr revenue CAGR
PROV
PROV
Annualised
PROV
2.3%
-0.1%
CCEL

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
CCEL
CCEL
PROV
PROV
Revenue
$7.8M
$9.8M
Net Profit
$-3.8M
$1.4M
Gross Margin
77.9%
Operating Margin
-50.6%
20.8%
Net Margin
-48.7%
14.6%
Revenue YoY
-2.3%
2.5%
Net Profit YoY
-105.1%
64.7%
EPS (diluted)
$-0.46
$0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCEL
CCEL
PROV
PROV
Q4 25
$7.8M
$9.8M
Q3 25
$7.8M
$9.7M
Q2 25
$7.9M
$9.8M
Q1 25
$8.0M
$10.1M
Q4 24
$8.0M
$9.6M
Q3 24
$8.1M
$9.5M
Q2 24
$8.0M
$9.9M
Q1 24
$7.9M
$9.4M
Net Profit
CCEL
CCEL
PROV
PROV
Q4 25
$-3.8M
$1.4M
Q3 25
$749.4K
$1.7M
Q2 25
$355.8K
$1.6M
Q1 25
$282.9K
$1.9M
Q4 24
$-1.9M
$872.0K
Q3 24
$1.1M
$1.9M
Q2 24
$655.8K
$2.0M
Q1 24
$556.2K
$1.5M
Gross Margin
CCEL
CCEL
PROV
PROV
Q4 25
77.9%
Q3 25
77.0%
Q2 25
76.6%
Q1 25
75.1%
Q4 24
78.4%
Q3 24
73.6%
Q2 24
74.8%
Q1 24
73.7%
Operating Margin
CCEL
CCEL
PROV
PROV
Q4 25
-50.6%
20.8%
Q3 25
24.3%
28.1%
Q2 25
18.8%
23.6%
Q1 25
13.3%
26.2%
Q4 24
-1.5%
12.7%
Q3 24
17.2%
28.3%
Q2 24
17.3%
27.8%
Q1 24
10.5%
22.5%
Net Margin
CCEL
CCEL
PROV
PROV
Q4 25
-48.7%
14.6%
Q3 25
9.6%
17.3%
Q2 25
4.5%
16.7%
Q1 25
3.5%
18.4%
Q4 24
-23.2%
9.1%
Q3 24
13.0%
20.0%
Q2 24
8.2%
19.7%
Q1 24
7.1%
15.9%
EPS (diluted)
CCEL
CCEL
PROV
PROV
Q4 25
$-0.46
$0.22
Q3 25
$0.09
$0.25
Q2 25
$0.04
$0.24
Q1 25
$0.03
$0.28
Q4 24
$-0.23
$0.13
Q3 24
$0.13
$0.28
Q2 24
$0.08
$0.28
Q1 24
$0.07
$0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCEL
CCEL
PROV
PROV
Cash + ST InvestmentsLiquidity on hand
$3.3M
$54.4M
Total DebtLower is stronger
$8.4M
Stockholders' EquityBook value
$-18.6M
$127.5M
Total Assets
$61.7M
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCEL
CCEL
PROV
PROV
Q4 25
$3.3M
$54.4M
Q3 25
$3.2M
$49.4M
Q2 25
$4.4M
$53.1M
Q1 25
$3.5M
$50.9M
Q4 24
$3.5M
$45.5M
Q3 24
$2.1M
$48.2M
Q2 24
$1.5M
$51.4M
Q1 24
$979.6K
$51.7M
Total Debt
CCEL
CCEL
PROV
PROV
Q4 25
$8.4M
Q3 25
$8.4M
Q2 25
$8.4M
Q1 25
$8.5M
Q4 24
$8.5M
Q3 24
$8.5M
Q2 24
$8.5M
Q1 24
$8.6M
Stockholders' Equity
CCEL
CCEL
PROV
PROV
Q4 25
$-18.6M
$127.5M
Q3 25
$-14.8M
$128.4M
Q2 25
$-15.6M
$128.5M
Q1 25
$-14.7M
$128.9M
Q4 24
$-13.2M
$128.6M
Q3 24
$-9.6M
$129.6M
Q2 24
$-10.7M
$129.9M
Q1 24
$-10.3M
$129.5M
Total Assets
CCEL
CCEL
PROV
PROV
Q4 25
$61.7M
$1.2B
Q3 25
$63.2M
$1.2B
Q2 25
$64.4M
$1.2B
Q1 25
$64.4M
$1.3B
Q4 24
$64.7M
$1.3B
Q3 24
$62.9M
$1.3B
Q2 24
$62.6M
$1.3B
Q1 24
$61.7M
$1.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCEL
CCEL
PROV
PROV
Operating Cash FlowLast quarter
$1.3M
$1.2M
Free Cash FlowOCF − Capex
$1.2M
$1.0M
FCF MarginFCF / Revenue
15.5%
10.5%
Capex IntensityCapex / Revenue
0.9%
1.9%
Cash ConversionOCF / Net Profit
0.85×
TTM Free Cash FlowTrailing 4 quarters
$5.2M
$14.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCEL
CCEL
PROV
PROV
Q4 25
$1.3M
$1.2M
Q3 25
$2.5M
$2.5M
Q2 25
$707.0K
$8.7M
Q1 25
$954.1K
$3.3M
Q4 24
$2.2M
$324.0K
Q3 24
$2.4M
$2.6M
Q2 24
$1.8M
$5.7M
Q1 24
$-356.9K
$3.0M
Free Cash Flow
CCEL
CCEL
PROV
PROV
Q4 25
$1.2M
$1.0M
Q3 25
$2.5M
$2.5M
Q2 25
$644.6K
$8.2M
Q1 25
$892.0K
$3.3M
Q4 24
$2.1M
$307.0K
Q3 24
$2.3M
$2.4M
Q2 24
$21.5K
$4.1M
Q1 24
$-814.6K
$2.6M
FCF Margin
CCEL
CCEL
PROV
PROV
Q4 25
15.5%
10.5%
Q3 25
31.9%
25.2%
Q2 25
8.1%
83.5%
Q1 25
11.2%
32.5%
Q4 24
26.8%
3.2%
Q3 24
27.9%
25.1%
Q2 24
0.3%
41.3%
Q1 24
-10.4%
27.5%
Capex Intensity
CCEL
CCEL
PROV
PROV
Q4 25
0.9%
1.9%
Q3 25
0.5%
0.5%
Q2 25
0.8%
5.4%
Q1 25
0.8%
0.3%
Q4 24
0.1%
0.2%
Q3 24
2.3%
1.8%
Q2 24
21.8%
16.0%
Q1 24
5.8%
4.2%
Cash Conversion
CCEL
CCEL
PROV
PROV
Q4 25
0.85×
Q3 25
3.38×
1.48×
Q2 25
1.99×
5.34×
Q1 25
3.37×
1.79×
Q4 24
0.37×
Q3 24
2.32×
1.35×
Q2 24
2.70×
2.91×
Q1 24
-0.64×
2.00×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons